MicroRNA expression changes after lung cancer resection

References

• Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H, et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 2004; 64:3753 - 6; http://dx.doi.org/10.1158/0008-5472.CAN-04-0637; PMID: 15172979
   PubMed Web of Science ®Google Scholar
• Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP, Pulford K, et al. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 2008; 141:672 - 5; http://dx.doi.org/10.1111/j.1365-2141.2008.07077.x; PMID: 18318758
   PubMed Web of Science ®Google Scholar
• Rabinowits G, Gerçel-Taylor C, Day JM, Taylor DD, Kloecker GH. Exosomal microRNA: a diagnostic marker for lung cancer. Clin Lung Cancer 2009; 10:42 - 6; http://dx.doi.org/10.3816/CLC.2009.n.006; PMID: 19289371
   PubMed Web of Science ®Google Scholar
• Keller A, Leidinger P, Gislefoss R, Haugen A, Langseth H, Staehler P, et al. Stable serum miRNA profiles as potential tool for non-invasive lung cancer diagnosis. RNA Biol 2011; 8:506 - 16; http://dx.doi.org/10.4161/rna.8.3.14994; PMID: 21558792
   PubMed Web of Science ®Google Scholar
• Lu M, Shi B, Wang J, Cao Q, Cui Q. TAM: a method for enrichment and depletion analysis of a microRNA category in a list of microRNAs. BMC Bioinformatics 2010; 11:419; http://dx.doi.org/10.1186/1471-2105-11-419; PMID: 20696049
   PubMed Web of Science ®Google Scholar
• Boeri M, Verri C, Conte D, Roz L, Modena P, Facchinetti F, et al. MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proc Natl Acad Sci U S A 2011; 108:3713 - 8; http://dx.doi.org/10.1073/pnas.1100048108; PMID: 21300873
   PubMed Web of Science ®Google Scholar
• Rauch TA, Wang Z, Wu X, Kernstine KH, Riggs AD, Pfeifer GP. DNA methylation biomarkers for lung cancer. Tumour Biol 2012; 33:287 - 96; http://dx.doi.org/10.1007/s13277-011-0282-2; PMID: 22143938
   PubMed Web of Science ®Google Scholar
• Yamada Y, Pannell R, Forster A, Rabbitts TH. The LIM-domain protein Lmo2 is a key regulator of tumour angiogenesis: a new anti-angiogenesis drug target. Oncogene 2002; 21:1309 - 15; http://dx.doi.org/10.1038/sj.onc.1205285; PMID: 11857074
   PubMed Web of Science ®Google Scholar
• Gantier MP, McCoy CE, Rusinova I, Saulep D, Wang D, Xu D, et al. Analysis of microRNA turnover in mammalian cells following Dicer1 ablation. Nucleic Acids Res 2011; 39:5692 - 703; http://dx.doi.org/10.1093/nar/gkr148; PMID: 21447562
   PubMed Web of Science ®Google Scholar
• Heneghan HM, Miller N, Lowery AJ, Sweeney KJ, Newell J, Kerin MJ. Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann Surg 2010; 251:499 - 505; http://dx.doi.org/10.1097/SLA.0b013e3181cc939f; PMID: 20134314
   PubMed Web of Science ®Google Scholar
• Komatsu S, Ichikawa D, Takeshita H, Tsujiura M, Morimura R, Nagata H, et al. Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma. Br J Cancer 2011; 105:104 - 11; http://dx.doi.org/10.1038/bjc.2011.198; PMID: 21673684
   PubMed Web of Science ®Google Scholar
• Kossenkov AV, Vachani A, Chang C, Nichols C, Billouin S, Horng W, et al. Resection of non-small cell lung cancers reverses tumor-induced gene expression changes in the peripheral immune system. Clin Cancer Res 2011; 17:5867 - 77; http://dx.doi.org/10.1158/1078-0432.CCR-11-0737; PMID: 21807633
   PubMed Web of Science ®Google Scholar
• Foss KM, Sima C, Ugolini D, Neri M, Allen KE, Weiss GJ. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer. J Thorac Oncol 2011; 6:482 - 8; http://dx.doi.org/10.1097/JTO.0b013e318208c785; PMID: 21258252
   PubMed Web of Science ®Google Scholar
• Keller A, Leidinger P, Gislefoss R, Haugen A, Langseth H, Staehler P, et al. Stable serum miRNA profiles as potential tool for non-invasive lung cancer diagnosis. RNA Biol 2011; 8:506 - 16; http://dx.doi.org/10.4161/rna.8.3.14994; PMID: 21558792
   PubMed Web of Science ®Google Scholar
• Brase JC, Johannes M, Schlomm T, Fälth M, Haese A, Steuber T, et al. Circulating miRNAs are correlated with tumor progression in prostate cancer. Int J Cancer 2011; 128:608 - 16; http://dx.doi.org/10.1002/ijc.25376; PMID: 20473869
   PubMed Web of Science ®Google Scholar
• Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 2008; 105:10513 - 8; http://dx.doi.org/10.1073/pnas.0804549105; PMID: 18663219
   PubMed Web of Science ®Google Scholar
• Hou J, Aerts J, den Hamer B, van Ijcken W, den Bakker M, Riegman P, et al. Gene expression-based classification of non-small cell lung carcinomas and survival prediction. PLoS One 2010; 5:e10312; http://dx.doi.org/10.1371/journal.pone.0010312; PMID: 20421987
   PubMed Web of Science ®Google Scholar
• Shimakage M, Takami K, Kodama K, Mano M, Yutsudo M, Inoue H. Expression of drs mRNA in human lung adenocarcinomas. Hum Pathol 2002; 33:615 - 9; http://dx.doi.org/10.1053/hupa.2002.125373; PMID: 12152160
   PubMed Web of Science ®Google Scholar
• Kobayashi D, Kuribayashi K, Tanaka M, Watanabe N. Overexpression of SALL4 in lung cancer and its importance in cell proliferation. Oncol Rep 2011; 26:965 - 70; PMID: 21725617
   PubMed Web of Science ®Google Scholar
• Pernemalm M, De Petris L, Eriksson H, Brandén E, Koyi H, Kanter L, et al. Use of narrow-range peptide IEF to improve detection of lung adenocarcinoma markers in plasma and pleural effusion. Proteomics 2009; 9:3414 - 24; http://dx.doi.org/10.1002/pmic.200800814; PMID: 19609957
   PubMed Web of Science ®Google Scholar
• Shen J, Liu Z, Todd NW, Zhang H, Liao J, Yu L, et al. Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers. BMC Cancer 2011; 11:374; http://dx.doi.org/10.1186/1471-2407-11-374; PMID: 21864403
   PubMed Web of Science ®Google Scholar
• Kroh EM, Parkin RK, Mitchell PS, Tewari M. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods 2010; 50:298 - 301; http://dx.doi.org/10.1016/j.ymeth.2010.01.032; PMID: 20146939
   PubMed Web of Science ®Google Scholar
• Wei J, Gao W, Zhu CJ, Liu YQ, Mei Z, Cheng T, et al. Identification of plasma microRNA-21 as a biomarker for early detection and chemosensitivity of non-small cell lung cancer. Chin J Cancer 2011; 30:407 - 14; http://dx.doi.org/10.5732/cjc.010.10522; PMID: 21627863
   PubMedGoogle Scholar
• Laczny C, Leidinger P, Haas J, Ludwig N, Backes C, Gerasch A, et al. miRTrail - a comprehensive webserver for analyzing gene and miRNA patterns to enhance the understanding of regulatory mechanisms in diseases. BMC Bioinformatics 2012; 13:36; http://dx.doi.org/10.1186/1471-2105-13-36; PMID: 22356618
   PubMed Web of Science ®Google Scholar
• Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 2003; 13:2498 - 504; http://dx.doi.org/10.1101/gr.1239303; PMID: 14597658
   PubMed Web of Science ®Google Scholar